Article Details

Week In Review: Luye May Stage $500 Million Singapore IPO Of Healthcare Assets

Retrieved on: 2018-01-27 20:00:00

Tags for this article:

Click the tags to see associated articles and topics

Week In Review: Luye May Stage $500 Million Singapore IPO Of Healthcare Assets. View article details on hiswai:

Excerpt

<div>In its Series C-1 funding, completed in August 2017, ARMO raised $67 million led by China investor Qiming Ventures, and joined by new China investors Decheng Capital, <b>Sequoia Capital</b>, Quan Capital and RTW Investments. ARMO's lead molecule is AM0010, a pegylated form of Interleukin-10, which ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up